Delivery Order SPE2DB24D2205-SPE2DB25FDSHX

Award Date 10/7/24
Potential Completion Date 10/8/24
Potential Value $46K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $5,523 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4565440991 - MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The award has an ultimate completion date of August 14, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
The Defense Logistics Agency (DLA) awarded a $3,419.00 Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division, a leading pharmaceutical distributor. The contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a prescription medication. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC,...
The Defense Logistics Agency (DLA) awarded a $3,208.20 firm fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of the pharmaceutical product MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML. This contract has a completion date of May 14, 2024 and was awarded on May 13, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to...
The Defense Logistics Agency (DLA) awarded a $1,052.00 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the provision of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML pharmaceuticals. This award is under Amerisourcebergen's $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
The U.S. Defense Logistics Agency (DLA) awarded a $29,820.51 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This order is part of Amerisourcebergen's single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $2,104.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The delivery order is for MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of February 21, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $4,269.99 to Amerisourcebergen Drug Corp, a division of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, with a completion date of February 16, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $5,260.00 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division for the supply of 4565629840 - MOUNJARO 15 MG/0.5 ML PEN 0.5ML. This contract has an ultimate completion date of August 30, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,026.03 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, with a period of performance through July 15, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,156.00 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. This contract is for the supply of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a performance period through May 30, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDSHX
    Delivery Order

The Defense Logistics Agency (DLA) awarded a $46,283.61 firm fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4566043683 MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This order has an ultimate completion date of October 8, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical for delivering a range of medical commodities to support military treatment programs and facilities worldwide. The company also has an IDC valued up to $750,000 with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. This contract award does not utilize any set-aside designation.

Generated 1/6/25, 12:36 PM